Table of Contents Author Guidelines Submit a Manuscript
Anemia
Volume 2012, Article ID 938140, 6 pages
http://dx.doi.org/10.1155/2012/938140
Research Article

An Epidemiological Study of Anemia and Renal Dysfunction in Patients Admitted to ICUs across the United States

1Department of Pharmacotherapy and Outcomes Science, VCU School of Pharmacy, P.O. Box 980533, Richmond, VA 23298-0533, USA
2Division of Nephrology, VCU School of Medicine, Richmond, VA 23298, USA
3Department of Epidemiology and Community Health, VCU School of Medicine, Richmond, VA 23298, USA
4Department of Neurosurgery, VCU School of Medicine, Richmond, VA 23298, USA

Received 27 February 2012; Revised 16 April 2012; Accepted 25 April 2012

Academic Editor: Eitan Fibach

Copyright © 2012 Donald F. Brophy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. L. Corwin and J. L. Carson, “Blood transfusion—when is more really less?” The New England Journal of Medicine, vol. 356, no. 16, pp. 1667–1669, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. J. L. Vincent, J. F. Baron, L. Reinhart, L. Gattinoni et al., “Anemia and blood transfusion in critically ill patients,” Journal of the American Medical Association, vol. 288, no. 12, pp. 1499–1507, 2002. View at Google Scholar · View at Scopus
  3. H. L. Corwin, A. Gettinger, R. G. Pearl et al., “The CRIT Study: anemia and blood transfusion in the critically ill—current clinical practice in the United States,” Critical Care Medicine, vol. 32, no. 1, pp. 39–52, 2004. View at Google Scholar · View at Scopus
  4. H. L. Corwin, A. Gettinger, T. C. Fabian et al., “Efficacy and safety of epoetin alfa in critically ill patients,” The New England Journal of Medicine, vol. 357, no. 10, pp. 965–976, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. R. W. Taylor, J. O'Brien, S. J. Trottier et al., “Red blood cell transfusions and nosocomial infections in critically ill patients,” Critical Care Medicine, vol. 34, no. 9, pp. 2302–2308, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Netzer, C. V. Shah, T. J. Iwashyna et al., “Association of RBC transfusion with mortality in patients with acute lung injury,” Chest, vol. 132, no. 4, pp. 1116–1123, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. M. A. Croce, E. A. Tolley, J. A. Claridge et al., “Transfusions result in pulmonary morbidity and death after a moderate degree of injury,” Journal of Trauma, vol. 59, no. 1, pp. 19–24, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. R. J. DeBellis, “Anemia in critical care patients: incidence, etiology, impact, management, and use of treatment guidelines and protocols,” American Journal of Health-System Pharmacy, vol. 64, no. 3, pp. S14–S21, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. P. A. Carless, D. A. Henry, J. L. Carson et al., “Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion,” Cochrane Database of Systematic Reviews, vol. 6, no. 10, Article ID CD002042, 2010. View at Google Scholar · View at Scopus
  10. L. M. Napolitano, S. Kurek, F. A. Luchette et al., “Clinical practice guideline: red blood cell transfusion in adult trauma and critical care,” Journal of Trauma, vol. 67, no. 6, pp. 1439–1442, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. A. S. Levey, J. P. Bosch, J. B. Lewis, T. Greene, N. Rogers, and D. Roth, “A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation,” Annals of Internal Medicine, vol. 130, no. 6, pp. 461–470, 1999. View at Google Scholar · View at Scopus
  12. K. C. Schneider, Overview of the RDRG Severity System, Health Systems Consultants, New Haven, Conn, USA, 2008.
  13. J. L. Freeman, R. B. Fetter, H. Park et al., “Diagnosis-related group refinement with diagnosis- and procedure-specific comorbidities and complications.,” Medical Care, vol. 33, no. 8, pp. 806–827, 1995. View at Google Scholar · View at Scopus
  14. H. L. Corwin, A. Gettinger, R. G. Pearl et al., “Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial,” Journal of the American Medical Association, vol. 288, no. 22, pp. 2827–2835, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. L. M. Napolitano, T. C. Fabian, K. M. Kelly et al., “Improved survival of critically ill trauma patients treated with recombinant human erythropoietin,” The Journal of Trauma, vol. 65, no. 2, pp. 285–299, 2008. View at Google Scholar · View at Scopus
  16. D. F. Brophy, G. Daniel, M. Gitlin, and T. J. Mayne, “Characterizing hospitalizations of end-stage renal disease patients on dialysis and inpatient utilization of erythropoiesis-stimulating agent therapy,” Annals of Pharmacotherapy, vol. 44, no. 1, pp. 43–49, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. P. C. Hébert, G. Wells, M. A. Blajchman et al., “A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care,” The New England Journal of Medicine, vol. 340, no. 6, pp. 409–417, 1999. View at Publisher · View at Google Scholar · View at Scopus